Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Amortization of Deferred Charges (2019 - 2025)

AdaptHealth (AHCO) has 7 years of Amortization of Deferred Charges data on record, last reported at $1.3 million in Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges fell 13.08% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $5.7 million, changed 0.0%, while the annual FY2025 figure was $5.7 million, 0.0% changed from the prior year.
  • Amortization of Deferred Charges reached $1.3 million in Q4 2025 per AHCO's latest filing, down from $1.3 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.8 million in Q2 2025 and bottomed at $894000.0 in Q1 2021.
  • Average Amortization of Deferred Charges over 5 years is $1.4 million, with a median of $1.3 million recorded in 2021.
  • Peak YoY movement for Amortization of Deferred Charges: soared 334.24% in 2021, then dropped 25.75% in 2022.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $1.3 million in 2021, then dropped by 2.67% to $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then grew by 14.05% to $1.5 million in 2024, then fell by 13.08% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $1.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.8 million in Q2 2025.